Legal Status

Ibogaine is a controlled drug in the UK

Ibogaine is listed as a Class A drug under the Misuse of Drugs Act 1971 and is a Schedule 1 controlled drug under the Misuse of Drugs Regulations 2001. The UK-wide framework applies across England, Wales, Scotland, and Northern Ireland. Schedule 1 is the category subject to the highest level of restriction, with possession generally prohibited except where a lawful authority applies.

The statutory wording and current schedules should be checked against the official Misuse of Drugs Act 1971 and the relevant regulations rather than relying on a seller’s description or an older online summary. The broader legal background to controlled substances is also set out in the Misuse of Drugs Act overview.

Possession, supply, import and export are separate legal questions

For a controlled drug, the law can distinguish between possession, producing or supplying, offering to supply, and importing or exporting. The facts matter: quantity, communications, packaging, knowledge, intent, and any claimed authority can all be relevant. It is not safe to assume that describing something as personal use, research, a botanical, or a wellness product resolves those issues.

Cross-border travel adds further risk. Bringing material into the UK, including by post or courier, can engage import controls even where a person says it was obtained abroad or intended for personal use. Online listings, payment confirmation, and a promise of discreet delivery are not evidence that an item can lawfully enter the country.

For a live situation involving an item, a delivery, travel, an investigation, or a prosecution, seek advice from a solicitor with relevant criminal and regulatory experience. This page is not legal advice.

Plant material and isolated alkaloid should not be treated as interchangeable

Ibogaine is an alkaloid associated with Tabernanthe iboga, but legal analysis should not stop at a label such as “root bark,” “extract,” or “plant material.” The chemical content, preparation, representation, and applicable controlled-drug definitions may all matter. A product can also raise separate questions about medicines regulation, consumer claims, and product identity.

For an explanation of how alkaloids are understood as a chemical class, see the Encyclopaedia Britannica definition of alkaloids. That background does not decide the legal status of a particular product or shipment.

Research and clinical work require formal routes, not private workarounds

Schedule 1 research requires a tightly controlled setting and may require a Home Office controlled-drugs licence. Depending on the activity, medicines and tissue rules can add further obligations. The government guidance on controlled-drugs licences describes the licensing framework; it should be read alongside the requirements relevant to the proposed work.

Where a product is developed, tested, or presented as a medicine, the Medicines and Healthcare products Regulatory Agency may be relevant. Human tissue may also bring the Human Tissue Authority into scope in particular circumstances. These are institutional and regulatory pathways, not a route for private possession or self-directed treatment.

If you are trying to assess a claim about a provider or programme, the site’s evidence-checking approach sets out practical questions that can help separate assertions from verifiable information.